Short Sellers Still Targeting Retail, Biotech ETFs
Wayne Duggan, 18 February 2021
After a huge second half of 2020, the S&P 500 is off to another hot start to 2021. With stock market valuations getting more bloated by the week, there are plenty of skeptics that believe certain stocks and sectors have come too far too fast.
There is currently $244 billion in aggregate domestic ETF short interest, according to S3 Partners analyst Ihor Dusaniwsky. Over the past month, Dusaniwsky said short sellers have increased their exposure by about $14 billion. Continue reading “Article: Short Sellers Still Targeting Retail, Biotech ETFs”
